Outcome of Infants Younger Than 1 Year with Acute Lymphoblastic Leukemia Treated with the Interfant-06 Protocol; Results from an International Randomised Study
Rob Pieters(Princess Máxima Center), Maria Grazia Valsecchi(University of Milano-Bicocca), Benoît Brethon(Hôpital Saint-Louis), Luis Aversa, Christina Peters(Cancer Research Institute of the Slovak Academy of Sciences), Alina Ferster(Université Libre de Bruxelles), Martin Schrappe(University Hospital Schleswig-Holstein), Franco Locatelli(Bambino Gesù Children's Hospital), Gabriele Escherich(Universität Hamburg), Myriam Campbell, Jan Starý(Charles University), Lewis B. Silverman(Columbia University Irving Medical Center), Andrea Biondi(University of Milano-Bicocca), Birgitte Lausen(Nordic Society of Gynecologic Oncology), Jeffrey E. Rubnitz(St. Jude Children's Research Hospital), Ajay Vora(Great Ormond Street Hospital), Tomasz Szczepański(Medical University of Silesia), Rebecca Gardner(Seattle Children's Hospital), Andishe Attarbaschi(Cancer Research Institute of the Slovak Academy of Sciences), Chi Kong Li(Chinese University of Hong Kong), Rishi S. Kotecha(The Kids Research Institute Australia), Paola De Lorenzo(University of Milano-Bicocca), Philip Ancliffe(Children with Cancer UK)
Cited by 7
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
|The Lancet Oncology|2009|1k